· China Biopharma Industry Development Status Opportunities

· Gene Editing Humanized Mouse Tech and Solutions

· Recent Advances in Nanobody Platform Drugs

· Detection Method and QC Standard for Monoclonal Antibody

· Immunogenicity Assessment Strategies for Bio-Innovative Drugs

· Solid Tumor Cell Immunotherapy

· Regulatory Evolution of Cell Therapy

· Recent Advances in Cellular Immunotherapy for Solid Tumors

· Progress in the Production Process of Cell Therapy Products

· QC for Cell Therapy Products

· Cell Therapy Automated Production Equipment

· Interpretation of Relevant Policies and Regulations

· Expectation and Future Prospects of Biosimilars in China

· Application of HDX-MS in advanced structural characterization of biomacromolecules drug

· Novel Immunomodulatory Targets & Next Generation Active Immune Checkpoint Control Immunotherapy

· Biosimilar Clinical Research Seamless Connecting

· PK/PD Statistical Considerations for Clinical Trials of Biosimilars

· Recombinant Protein Downstream Process Strategy

· Industrialization of Oral Delivery Protein Drug and Formula Food for Special Medical Use

· Oncology Drug Development Based on Ion Channel and Transporter Studies of Label-free Ion Currents

· Laboratory Overall Construction and Management